Use of Lispro Insulin and Quality of Life in Adolescents on Intensive Therapy

The Diabetes Educator

Volumn 25, Issue 6, 1999, Pages 934-941

  Gray, Margaret ^a   Boland, Elizabeth A ^b   Tamborlane, William V ^b  

^a YALE UNIVERSITY SCHOOL OF NURSING   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; DRUG DERIVATIVE; INSULIN; INSULIN LISPRO;

ADAPTIVE BEHAVIOR; ADOLESCENT; ARTICLE; CHILD PSYCHOLOGY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; METABOLISM; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE;

ADAPTATION, PSYCHOLOGICAL; ADOLESCENT; ADOLESCENT PSYCHOLOGY; DIABETES MELLITUS, TYPE 1; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 0033218047     PISSN: 01457217     EISSN: None     Source Type: Journal    
DOI: 10.1177/014572179902500611     Document Type: Article

References (29)

1. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329: 977-986.
2. Diabetes Control and Complications Trial Research Group. Effect of intensive insulin treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J Pediatr. 1994;125:177-188.
3. Wilde Ml, McTavish D. Insulin lispro: a review of its pharmacological properties and therapeutic use in the management of diabetes mellitus. Drugs. 1997;54:597-614.
4. Jehle PA, Fussgainger RD, Kunze U, Dolderer M, Warchol W, Koop I. The human insulin analog insulin lispro improves insulin binding in circulating monocytes of intensively treated insulin-dependent diabetes mellitus patients. J Clin Endocrinol Metab. 1996;81: 2319-2327.
5. Amiel SA, Sherwin RS, Simonson DC, Lauritano AA, Tamborlone WV. Impaired insulin action in puberty: a contributing factor to poor glycemic control in adolescents. N Engl J Med. 1986;315:215-219.
6. Travis LB, Brouhard BH, Schreiner BJ. Diabetes Mellitus in Children and Adolescents. Philadelpha: WB Saunders; 1987.
7. Diabetes Control and Complications Trial Research Group. Reliability and validity of a Diabetes Quality-of-Life Measure for the Diabetes Control and Complications Trial. Diabetes Care. 1988;11:725-732.
8. Diabetes Control and Complications Trial Research Group. Influence of intensive diabetes treatment on quality-of-life outcomes in the Diabetes Control and Complications Trial. Diabetes Care. 1996;19:195-203.
9. Jacobson AM, Samson JA, deGroot M. The evaluation of two measures of quality of life in patients with type 1 and type 2 diabetes. Diabetes Care. 1994;17:267-274.
10. Ingersoll GM, Marrero DG. A modified Quality-of-Life Measure for youths: psychometric properties. Diabetes Educ. 1991;17:114-118.
11. Grey M, Boland EA, Yu C, Sullivan-Bolyai S, Tamborlane WV. Personal and social factors associated with quality of life in adolescents with IDDM. Diabetes Care. 1998;21:909-914.
12. Kotsanos JG, Vignati L, Huster W, et al. Health-related quality of life results from multinational clinical trials of insulin lispro. Diabetes Care. 1997;20:948-958.
13. Davidson M, Boland EA, Grey M. Teaching teens to cope: coping skills training for adolescents with diabetes mellitus. J Soc Pediatr Nurses. 1997;2:65-72.
14. Grossman HY, BrinkS, Hauser ST. Self-efficacy in adolescent girls and boys with insulin-dependent diabetes mellitus. Diabetes Care. 1987;10:324-329.
15. Bandura A. Social Foundations of Thought and Action: A Social Cognitive Theory. Englewood Cliffs, NJ: Prentice Hall; 1986.
16. Kovacs M. The Children's Depression Inventory (CDI). Psychopharm Bull. 1985;21:995-998.
17. Smucker MR, Craighead WE, Craighead LW, Green BJ. Normative and reliability data for the Children's Depression Inventory. J Abn Child Psychol. 1986;14:25-29.
18. Kovacs M, Feinberg TF, Paulauskas S, Finkelstein R, Pollack M, Crouse-Novak M. Initial coping responses and psychological characteristics of children with insulin-dependent diabetes mellitus. J Pediatr. 1985;106:827-834.
19. Kovacs M, Brent D, Feinberg TF, Paulauskas S, Reid J. Children's self-reports of psychologic adjustment and coping strategies during the first year of insulin-dependent diabetes mellitus. Diabetes Care. 1986;9:472-479.
20. American Diabetes Association. Clinical practice recommendations. Diabetes Care. 1998;21 (suppl 1):S88-S90.
21. Diabetes Control and Complications Trial Research Group. The Diabetes Control and Complications Trial: design and methodologic implications for the feasibility phase. Diabetes. 1986;35:530-545.
22. Bradley C. The Well-Being Questionnaire. In: Bradley C, ed. Handbook of Psychology and Diabetes. Switzerland: Harwood; 1994:111-132.
23. Kleinbaum DG, Kupper LL, Morgenstern H. Stratified analysis. In: Kleinbaum DG, Kupper LL, Morgenstern H, eds. Epidemiologic Research: Principles and Quantitative Methods. Belmont, Calif: Lifetime Learning; 1982:320-376.
24. Elashoff N. Qery advisor [computer program]. Version 1.0. Boston, Mass: Statistical Solutions; 1995.
25. Charron-Prochownik D, Arslanian S. Women with diabetes-the adolescent years: a case study and review. Diabetes Spectrum. 1997;10:180-184.
26. Krolewski AS, Laffel LM, Krowlewski M, Quinn M, Warram JH. Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. N Engl J Med. 1995;332:1251-1255.
27. Warram JH, Manson JE, Krowlewski AS. Glycosylated hemoglobin and the risk of retinopathy in insulin-dependent diabetes mellitus. N Engl J Med. 1995;332:1305-1306.
28. Holleman F, Schmidt H, Rottiers R, Rees A, Symanowski S, Anderson JH. Reduced frequency of severe hypoglycemia and coma in well-controlled IDDM patients treated with insulin lispro. The Benelux-UK Insulin Lispro Study Group. Diabetes Care. 1997;20: 1827-1832.
29. Pfutzner A, Kustner E, Forst T, et al. Intensive insulin therapy with insulin lispro in patients with type 1 diabetes reduces the frequency of hypoglycemic episodes. Exp Clin Endocrinol Diabetes. 1996;104:25-30.